Sagent Pharmaceuticals, Inc. 4
4 · Sagent Pharmaceuticals, Inc. · Filed Feb 19, 2014
Insider Transaction Report
Form 4
Drake Lorin
VP, Sales and Marketing
Transactions
- Award
Common Stock
2014-02-18+4,960→ 26,091 total - Award
Stock Option to Buy
2014-02-18+8,865→ 8,865 totalExercise: $20.16Exp: 2024-02-18→ Common Stock (8,865 underlying)
Footnotes (1)
- [F1]The option vests in four equal annual installments beginning on February 18, 2015.